Evidence map›Paper›PMID 32997294›Full record

ArticleJournal of neurology2021

Action fluency identifies different sex, age, global cognition, executive function and brain activation profile in non-demented patients with Parkinson's disease.

Noémie Auclair-Ouellet, Alexandru Hanganu, Erin L Mazerolle, Stefan T Lang, Mekale Kibreab, Mehrafarin Ramezani, Angela Haffenden, Tracy Hammer, Jenelle Cheetham, Iris Kathol and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Brief tests for the assessment of language-executive functions: normative data for the Italian population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Noémie Auclair-OuelletFaculty of Medicine, School of Communication Sciences and Disorders, McGill University, 2001 McGill College, 8th floor, Montreal, QC, H3A 1G1, Canada. noemie.auclairouellet@mcgill.ca.ORCID http://orcid.org/0000-0002-7762-8459
Alexandru HanganuDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Erin L MazerolleDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Stefan T LangDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Mekale KibreabDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Mehrafarin RamezaniDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Angela HaffendenDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Tracy HammerDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Jenelle CheethamDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Iris KatholDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
G Bruce PikeDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Justyna SarnaDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Davide MartinoDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Oury MonchiDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
University of Calgary · CA

Funding

CIHR FAH-381468CIHR PJT-166123
6 · The paper itself

Abstract

Patients with Parkinson's disease (PD) have difficulties processing action words, which could be related to early cognitive decline. The action fluency test can be used to quickly and easily assess the processing of action words in PD. The goal of this study was to characterize how the action fluency test relates to personal characteristics, disease factors, cognition, and neural activity in PD. Forty-eight participants with PD (34 male, 14 female) and 35 control participants (16 male, 19 female) completed functional neuroimaging using a set-shifting task and a neuropsychological assessment including the action fluency test. PD participants with a score one standard deviation below the norm or lower on the action fluency test were identified. All PD participants with poor performance (PD-P, n = 15) were male. They were compared to male PD participants with scores within the normal range (PD-N, n = 19) and male healthy controls (HC, n = 16). PD-P were older, had lower global cognition scores, lower executive functions scores, and decreased activity in fronto-temporal regions compared with PD-N. There was no difference between the two PD groups in terms of the duration of the disease, dose of dopaminergic medication, and severity of motor symptoms. PD-N were younger than HC, but there was no other significant difference between these groups. The action fluency test identified a subgroup of PD patients with distinct sex, age, global cognition, executive functions, and brain activity characteristics. Implications for the evaluation of cognition are discussed.

Indexed as

Executive FunctionParkinson DiseaseBrainCognitionFemaleHumansMaleNeuropsychological TestsActionCognitionExecutive functionsFluencyParkinson’s diseasePrefrontal cortex

Identifiers

PMID32997294
OpenAlexW3090833900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.